Search

Your search keyword '"Thrombolytic therapy -- Research"' showing total 15 results
Start Over Descriptor "Thrombolytic therapy -- Research" Topic pharmaceuticals and cosmetics industries
15 results on '"Thrombolytic therapy -- Research"'

1. Thrombolytic therapy - still room for improvement

Author

White, Harvey

Subjects
Heart attack -- Care and treatment, Cardiac patients -- Patient outcomes, Tissue plasminogen activator -- Health aspects, Streptokinase -- Health aspects, Heparin -- Health aspects, Drug therapy, Combination -- Research, Thrombolytic therapy -- Research, Business, Pharmaceuticals and cosmetics industries
Published
1994

2. Benefits of early thrombolysis

Subjects
Thrombolytic therapy -- Research, Heart attack -- Research, Business, Pharmaceuticals and cosmetics industries, American College of Cardiology -- Reports
Published
1992

3. Study sheds light on the 'Lazarus phenomenon'

Subjects
Heart diseases -- Research -- Risk factors, Thrombolytic therapy -- Research, Stroke patients -- Research, Pharmaceuticals and cosmetics industries, Research, Risk factors
Abstract

Intra-arterial administration of thrombolytic therapy (mainly tissue-plasminogen activator [t-PA]) has demonstrated significant and immediate clinical improvement, dubbed the 'Lazarus phenomenon,' in about one-fourth of patients with acute ischemic stroke. Factors [...]

Published
2007

5. Hirulog promising with thrombolysis

Subjects
Biogen Inc. -- Research -- 00322550, Pharmaceutical industry -- Research, Antithrombins -- Research, Heart attack -- Drug therapy, Thrombolytic therapy -- Research, Streptokinase -- Health aspects, Business, Pharmaceuticals and cosmetics industries
Published
1996

6. Study: early treatment with thrombolytic t-PA for stroke

Subjects
Health care industry -- Research, Thrombolytic therapy -- Research, Stroke (Disease) -- Care and treatment, Stroke (Disease) -- Research, Assistance in emergencies -- Research, Health care industry, Pharmaceuticals and cosmetics industries
Abstract

A study in the March 6 issue of The Lancet confirms the benefits of getting stroke patients to the hospital quickly for rapid thrombolytic treatment, according to the National Institute [...]

Published
2004

8. Treatment of heart attacks improving

Subjects
Thrombolytic therapy -- Research, Heart attack -- Drug therapy, Business, Pharmaceuticals and cosmetics industries
Published
1994

9. Progress with hirudin/hirulog in thrombolysis/unstable angina

Subjects
Ciba-Geigy Corp. -- Product information, Biogen Inc. -- Product information, Pharmaceutical industry -- Product information, Antithrombins -- Research, Thrombolytic therapy -- Research, Streptokinase -- Research, Unstable angina -- Care and treatment, Business, Pharmaceuticals and cosmetics industries
Published
1994

10. RheothRx benefits with thrombolysis

Subjects
CytoRx -- Product information, Wellcome -- Product information, Cardiovascular agents -- Research, Thrombolytic therapy -- Research, Cardiac patients -- Care and treatment, Heart attack -- Care and treatment, Business, Pharmaceuticals and cosmetics industries, RheothRx (Medication) -- Research
Published
1994

11. Late thrombolysis studies published

Subjects
Heart attack -- Drug therapy, Thrombolytic therapy -- Research, Tissue plasminogen activator -- Physiological aspects, Placebos -- Physiological aspects, Streptokinase -- Physiological aspects, Business, Pharmaceuticals and cosmetics industries, Activase (Medication) -- Physiological aspects
Published
1993

12. Thrombolysis in PAO study discontinued

Subjects
Thrombolytic therapy -- Research, Arterial occlusions -- Care and treatment, Business, Pharmaceuticals and cosmetics industries
Published
1993

13. Double bolus TPA - the future?

Subjects
Tissue plasminogen activator -- Dosage and administration, Dose-response relationship (Biochemistry) -- Analysis, Thrombolytic therapy -- Research, Business, Pharmaceuticals and cosmetics industries
Published
1993

14. Scientists Suggest Therapy Targets Tissue Damage Prevention

Subjects
Stroke (Disease) -- Research, Thrombolytic therapy -- Research, Biotechnology industry, Pharmaceuticals and cosmetics industries, Scripps Clinic and Research Foundation -- Research
Abstract

2001 FEB 14 - (NewsRx.com) -- Scientists at The Scripps Research Institute (TSRI), La Jolla, California, along with their colleagues at Henry Ford Health Sciences Center, Detroit, Michigan, reported findings [...]

Published
2001

15. Reduction of thrombolysis delays

Subjects
Thrombolytic therapy -- Research, Heart attack -- Care and treatment, Business, Pharmaceuticals and cosmetics industries
Published
1992

Catalog

Books, media, physical & digital resources
See catalog results